Ligand Pro
Ligand Pro is a Russian company specializing in early-stage drug development using artificial intelligence and computational methods. They create digital tools to accelerate the development of promising drug candidates. Their core offerings include de novo generation of small molecules with optimal property profiles, prediction of small molecule interactions with therapeutic targets, optimization of protein properties, and prediction of small molecule properties (ADME-Tox). Ligand Pro collaborates with research groups, pharmaceutical companies, and startups, validating their AI-driven approaches in real-world drug development pipelines. The company was founded in 2023 and is supported by Postgres Professional, with a team that includes members from Skoltech.
Ligand Pro
Ligand Pro is a Russian company specializing in early-stage drug development using artificial intelligence and computational methods. They create digital tools to accelerate the development of promising drug candidates. Their core offerings include de novo generation of small molecules with optimal property profiles, prediction of small molecule interactions with therapeutic targets, optimization of protein properties, and prediction of small molecule properties (ADME-Tox). Ligand Pro collaborates with research groups, pharmaceutical companies, and startups, validating their AI-driven approaches in real-world drug development pipelines. The company was founded in 2023 and is supported by Postgres Professional, with a team that includes members from Skoltech.